
ZEJULA is a prescription medicine used for the maintenance treatment of adults with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, when the cancer comes back. ZEJULA is used after the cancer has responded (complete or partial response) to treatment with platinum-based chemotherapy.
It is not known if ZEJULA is safe and effective in children.

Your healthcare provider will do blood tests to check your blood cell counts:
Ask your healthcare provider if you do not know.
Before taking ZEJULA, tell your healthcare provider about all of your medical conditions, including if you:
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use ZEJULA for a condition for which it was not prescribed. Do not give ZEJULA to other people, even if they have the same symptoms that you have. It may harm them.
Active ingredient: Niraparib
Inactive ingredient: Capsule fill: magnesium stearate and lactose monohydrate
Capsule shell: titanium dioxide and gelatin in the white capsule body and FD&C Blue #1, FD&C Red
#3, FD&C Yellow #5 and gelatin in the purple capsule cap.
The black printing ink: shellac, dehydrated alcohol, isopropyl alcohol, butyl alcohol, propylene glycol,
purified water, strong ammonia solution, potassium hydroxide and black iron oxide.
The white pritnting ink: shellac, dehydrated alcohol, isopropyl alcohol, butyl alcohol, propylene glycol,
sodium hydroxide, povidone and titanium oxide.